|
Please enjoy these articles. Click on the title to read the
entire article.
Please feel free to forward these to your friends. Also, please
remember to keep us in mind should you have a friend in need
of legal counsel with an injury claim.
Click here for a Free Initial Evaluation
Or Contact
Us:
jim@adlerandmanson.com
bill@adlerandmanson.com
816.333.0400
Toll Free: 877.336.0400
In
this issue: Tanning Beds Cause Cancer, Study Says
A new study has concluded that the use of tanning beds raised the risk of skin cancer by 75 percent among persons who began tanning before age 30. The risk assessment, produced by the International Agency for Research on Cancer, now classifies tanning beds in the same category as carcinogens such as cigarettes. The study appears in the medical journal Lancet Oncology. Eva von Schaper, Bloomberg 07/28/2009
Texting Significantly Increases Crash Risk, Study Says
Sending or receiving text messages while driving significantly increased the risk of collisions among long-haul truck drivers, a new study has concluded. According to the study, the truckers took their eyes off the road for about five seconds while texting. Researchers say that while the study focused on truckers, the finding can be applied to all drivers. Matt Richtel, The New York Times 07/27/2009
Officials: Popular Supplements Contain Steroids
Federal authorities announced Thursday that two popular over-the-counter supplements commonly used by high school athletes also contain steroids, the New York Times reports. According to the Food and Drug Administration and other agencies, the supplements Tren Xtreme and Mass Xtreme contain designer steroids that help athletes gain strength and muscle mass quickly. The supplements are manufactured by American Cellular and Labs and are believed to be especially popular among high school football players. Michael S. Schmidt and Natasha Singer, The New York Times 07/23/2009
FDA Finds Carcinogens in Electronic Cigarettes
A new analysis by the Food and Drug Administration is casting doubt on the supposed safety of tobacco-free electronic cigarettes. Electronic cigarette manufacturers claim their products contain only nicotine, water vapor and an ingredient used to create artificial smoke. However, the FDA analysis concluded the devices contained known carcinogens and, in at least one case, an ingredient commonly used in antifreeze. Katie Zezima, The New York Times 07/22/2009
Debt Firm Names in Harassment Lawsuit
A Cleveland debt collection agency threatened, harassed and deceived consumers in violation of state and federal law, a lawsuit filed by the Ohio attorney general claims. According to the lawsuit, debt collectors with National Enterprise Systems of Solon used abusive language, failed to verify debts and made unauthorized withdrawals from consumer bank accounts. Officials in West Virginia have also filed a similar lawsuit against the firm. Steve Wartenberg, Columbus Dispatch 07/22/2009
After Tragedy, Wife Crusades for Safety
Following the death of her husband from a possible medical error, a Virginia woman has become an activist for patient safety, the Washington Post reports. Though the University of Michigan Medical Center has never admitted error for failing to identify the sepsis that caused Vincent Hereford’s death, his wife, Michelle, hopes her story will focus attention on hospital procedures that may lead to substandard care. Lisa Rein , The Washington Post 07/21/2009
FDA Links Asthma Drug, Xolair, to Heart Problems
The Food and Drug Administration has announced that the asthma drug Xolair MAY increase the risk of patients developing a host of cardiovascular problems. Data gathered from clinic trials showed that Xolair users were disproportionately more likely to suffer from blood clots, heart failure, stroke, cardiac arrhythmias and heart enlargement, the FDA said. However, the agency stopped short of establishing a causal link between the drug and heart problems. Melissa Healy, LA Times 07/16/2009
Study Links Hormone Therapy to Ovarian Cancer
A Danish study has concluded that women who undergo hormone replacement therapy following menopause are significantly more likely to develop ovarian cancer. According to the study, published in the Journal of the American Medical Association, women who took hormone replacements were 38 percent more likely to develop ovarian cancer than those who did not. A 2002 study by the Women’s Health Initiative produced similar findings. Andrew Stern, Reuters 07/14/2009
|
